Your browser doesn't support javascript.
loading
Quantitative Evaluation of Dendritic Nanoparticles in Mice: Biodistribution Dynamics and Downstream Tumor Efficacy Outcomes.
Vasalou, Christina; Ferguson, Douglas; Li, Weimin; Muse, Victorine; Gibbons, Francis D; Sonzini, Silvia; Zhang, Guangnong; Pop-Damkov, Petar; Gangl, Eric; Balachander, Srividya B; Wen, Shenghua; Schuller, Alwin G; Puri, Sanyogitta; Mazza, Mariarosa; Ashford, Marianne; Fretland, Adrian J; McGinnity, Dermot F; Jones, Rhys D O.
Affiliation
  • Vasalou C; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.
  • Ferguson D; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.
  • Li W; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K.
  • Muse V; Novo Nordisk Foundation Center for Protein Research, Copenhagen 2200, Denmark.
  • Gibbons FD; Biogen, Cambridge, Massachusetts 02142, United States.
  • Sonzini S; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K.
  • Zhang G; Dicerna Pharmaceuticals, Inc, Lexington, Massachusetts 02421, United States.
  • Pop-Damkov P; Takeda Pharmaceuticals, Cambridge, Massachusetts 02139, United States.
  • Gangl E; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.
  • Balachander SB; Bristol-Myers Squibb, Cambridge, Massachusetts 02142, United States.
  • Wen S; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.
  • Schuller AG; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.
  • Puri S; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K.
  • Mazza M; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K.
  • Ashford M; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K.
  • Fretland AJ; Repare Therapeutics, Cambridge, Massachusetts 02142, United States.
  • McGinnity DF; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.
  • Jones RDO; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.
Mol Pharm ; 19(1): 172-187, 2022 01 03.
Article in En | MEDLINE | ID: mdl-34890209
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Dendrimers / Nanoparticles / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Dendrimers / Nanoparticles / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2022 Type: Article Affiliation country: United States